Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor

Regulatory Peptides

Volumn 134, Issue 2-3, 2006, Pages 75-81

  Peng, Ya li ^a   Chang, Min ^a   Dong, Shou liang ^a   Li, Wei ^a   Han, Ren wen ^a   Fu, Guo xing ^a   Chen, Qiang ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Cardiovascular assay; Mouse colon (mC); Mouse vas deferens (mVD); N OFQ analogues; Nociceptin orphanin FQ (N OFQ); Tail withdrawal assay

Indexed keywords

NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTERIAL PRESSURE; ARTICLE; COLON; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; HYPOTENSION; IN VITRO STUDY; MALE; MOLECULAR MIMICRY; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; VAS DEFERENS;

ANIMALS; BLOOD PRESSURE; COLON; ELECTROPHYSIOLOGY; FEMALE; MALE; MICE; MUSCLE CONTRACTION; NALOXONE; OPIOID PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID; VAS DEFERENS;

ANIMALIA;

EID: 33646177255     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.01.003     Document Type: Article

References (29)

1. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
2. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
3. Cox B.M., Chavkin C., Christie M.J., Civelli O., Evans C., Hamon M.D., et al. Opioid receptors, in the IUPHAR compendium of receptor characterization and classification (2000), IUPHAR Media Ltd., London 321-333
4. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., et al. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 347 (1994) 279-283
5. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341 (1994) 33-38
6. Wang J.B., Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., Eppler C.M., et al. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348 (1994) 75-79
7. Calo G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 129 (2000) 1261-1283
8. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53 (2001) 381-415
9. Zaveri N. Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci 73 (2003) 663-678
10. Guerrini R., Calo G., Bigoni R., Rizzi A., Varani K., Toth G., et al. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. J Med Chem 43 (2000) 2805-2813
11. 2, a new selective nociceptin receptor antagonist. Br J Pharmacol 129 (2000) 1183-1193
12. Okada K., Sujaku T., Chuman Y., Nakashima R., Nose T., Costa T., et al. Highly potent nociceptin analog containing the Arg-Lys triple repeat. Biochem Biophys Res Commun 278 (2000) 493-498
13. 15]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies. J Pharmacol Exp Ther 300 (2002) 57-63
14. 2: identification of highly potent agonists of the nociceptin/orphanin FQ receptor. J Med Chem 44 (2001) 3956-3964
15. 4]nociceptin(1-13)amide analogues. 1, in vitro studies. Naunyn-Schmiedeberg's Arch Pharmacol 365 (2002) 442-449
16. 4]nociceptin(1-13)amide analogues. 2, in vivo studies. Naunyn-Schmiedeberg's Arch Pharmacol 365 (2002) 450-456
17. Zhang C.W., Miller W., Valenzano K.J., and Kyle D.J. Novel, potent ORL-1 receptor agonist peptides containing α-helix-promoting conformational constraints. J Med Chem 45 (2002) 5280-5286
18. 2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol 136 (2002) 303-311
19. Guerrini R., Calo G., Lambert D.G., Carra G., Arduin M., Barnes T.A., et al. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. J Med Chem 48 (2005) 1421-1427
20. 2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. J Pharmacol Exp Ther 312 (2005) 1114-1123
21. Chang M., Peng Y.L., Dong S.L., Han R.W., Li W., Yang D.J., et al. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor. Regul Pept 130 (2005) 116-122
22. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem 4 (1998) 3360-3366
23. Hughes J., Kosterlitz H.W., and Leslie F.M. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br J Pharmacol 53 (1975) 371-381
24. Fang Q., Gou J., Chang M., Chen L.X., Chen Q., and Wang R. Neuropeptide F.F. receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon. Peptides 26 (2005) 791-797
25. Li S.R., Wang T., Wang R., Dai X., Chen Q., and Li R.D. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice. Brain Res 1043 (2005) 132-138
26. 2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat. Can J Physiol Pharmacol 80 (2002) 31-35
27. 2 in mice. Neurosci Lett 316 (2001) 25-28
28. Marti M., Mela F., Veronesi C., Guarrini R., Salvadori S., Federici M., et al. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior. J Neurosci 24 (2004) 6659-6666
29. 2, a pure and selective nociceptin/orphanin FQ receptor antagonist. J Pept Res 57 (2001) 215-222